Press Releases

Find out the latest announcements and updates from Genialis. This is where you’ll find newest reports on our partnerships, collaborations, and achievements.

October 16, 2018|
Genialis Expands Portfolio of Multi-Omics Data Analysis Workflows to Extend Applications for Drug Discovery
November 14, 2017|
Genialis, Inc. Raises $2.3M Seed Round to Advance Visual Exploration of Genomics Data
October 10, 2017|
Baylor, Genialis team up for next generation sequencing

Media Kit

Boilerplate

Genialis provides therapeutic intelligence with its Supermodel of cancer biology. We develop and validate clinically actionable AI models informed by the world’s most ethnographically diverse cancer data sets to predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data.

The company is headquartered in Houston, Boston and Ljubljana.